GlassScriptPhysician profile
James R Allison
NPI 1750376521
$1,915.47
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,613 · 2020: $276 · 2021: $26.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $523.12 | 2019-2020 | |
| Novo Nordisk INC | $254.61 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.08 | 2019 | |
| Abbvie INC. | $140.73 | 2019-2021 | |
| Amgen INC. | $128.08 | 2019-2020 | |
| Alkermes, INC. | $125.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.73 | 2019-2020 | |
| Pfizer INC. | $82.03 | 2019-2020 | |
| Lilly USA, LLC | $47.59 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.89 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $37.35 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.97 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $28.84 | 2019 | |
| Astellas Pharma US INC | $27.98 | 2019 | |
| Allergan, INC. | $25.70 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $24.54 | 2020 | |
| Daiichi Sankyo INC. | $19.89 | 2020 | |
| Amarin Pharma, INC. | $15.89 | 2019 | |
| Sanofi Pasteur INC. | $15.61 | 2019 | |
| Shire North American Group INC | $14.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.37 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.49 | 2020 | |
| Hikma Pharmaceuticals USA | $11.35 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Allison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.